Scarica l'app Stockscreener
350.85
1.24%
4.29
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché WST Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$346.56
Aprire:
$345.36
Volume 24 ore:
1.23M
Relative Volume:
1.44
Capitalizzazione di mercato:
$24.79B
Reddito:
$3.22B
Utile/perdita netta:
$542.70M
Rapporto P/E:
46.90
EPS:
7.4805
Flusso di cassa netto:
$458.00M
1 W Prestazione:
+6.98%
1M Prestazione:
+10.97%
6M Prestazione:
+27.91%
1 anno Prestazione:
+60.21%
Intervallo 1D:
$342.70
$351.35
Intervallo di 1 settimana:
$324.68
$352.31
Portata 52W:
$206.80
$352.31
West Pharmaceutical Services Inc Stock (WST) Company Profile
Nome
West Pharmaceutical Services Inc
Settore
Industria
Telefono
(610) 594-2900
Indirizzo
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
350.85 | 24.79B | 3.22B | 542.70M | 458.00M | 7.4805 |
ISRG
Intuitive Surgical Inc
|
404.70 | 143.33B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
155.92 | 42.96B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.80 | 33.07B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
38.87 | 32.87B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
200.29 | 29.05B | 5.54B | 1.52B | 1.74B | 10.37 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-02 | Iniziato | Morgan Stanley | Equal-Weight |
| 2025-09-15 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-06-24 | Iniziato | Barclays | Equal Weight |
| 2025-03-18 | Iniziato | Evercore ISI | Outperform |
| 2025-02-14 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2025-01-08 | Iniziato | Citigroup | Buy |
| 2024-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2024-12-12 | Aggiornamento | UBS | Neutral → Buy |
| 2024-02-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-06-16 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-04-11 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Hold |
| 2022-11-30 | Iniziato | UBS | Neutral |
| 2022-10-28 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Iniziato | Stephens | Equal-Weight |
| 2020-07-21 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-04-24 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | Downgrade | Jefferies | Buy → Hold |
| 2019-04-23 | Iniziato | William Blair | Outperform |
| 2018-04-25 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | Iniziato | Goldman | Neutral |
| 2017-10-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | Iniziato | Stephens | Equal-Weight |
| 2017-09-15 | Aggiornamento | Jefferies | Hold → Buy |
| 2016-10-28 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | Iniziato | Wells Fargo | Outperform |
| 2010-05-14 | Reiterato | UBS | Neutral |
| 2010-02-23 | Iniziato | Jefferies & Co | Buy |
| 2008-12-19 | Iniziato | UBS | Neutral |
Mostra tutto
West Pharmaceutical Services Inc Borsa (WST) Ultime notizie
West Pharmaceutical steady on Friday, S&P 500 peer group shows mixed moves - Ad-hoc-news.de
Price to earnings forward of West Pharmaceutical Services, Inc. – NYSE:WST - TradingView
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
Is West Pharmaceutical stock outperforming the S&P 500? - MSN
Vest S&P 500 Dividend Aristocrats Target Income Fund's West Pharmaceutical Services Inc(WST) Holding History - GuruFocus
West Pharmaceutical adjusts guidance on GLP-1 demand, shares extend 30-day gain - Ad-hoc-news.de
Westar RS Lined Seal from West Pharmaceutical Services Inc.ready-for-use vial closure targets con - Ad-hoc-news.de
West Pharmaceutical Services, Inc. Actuals & Estimates (NYSE:WST) - TradingView
West Pharmaceutical Services Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
WST Forecast — Price Target — Prediction for 2027 - TradingView
West Pharmaceutical Services Inc (WST) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
West Pharmaceutical Services names Michel Lagarde as next CEO, effective Aug. 31 - MSN
West Pharmaceutical Services Inc (WST)'s Winning Formula: Financ - GuruFocus
West Pharmaceutical Services stock hits 52-week high at $338.73 - Investing.com
West Pharmaceutical Services stock hits 52-week high at $338.73 By Investing.com - Investing.com Canada
West Pharmaceutical Services, Inc. (WST) hit a 52 week high, can the run continue? - MSN
The SmartDose 10 mL system from West Pharmaceutical Services Inc.large-volume self-injection with - Ad-hoc-news.de
WST Stock Price and Chart — NYSE:WST - TradingView
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
West Pharmaceutical opens the week with clear analyst consensus, shares hold near recent highs - Ad-hoc-news.de
Revvity Launches Signals AI to Advance Scientific R&D Workflows - TradingView
Is West Pharmaceutical Services (WST) Pricey As GLP 1 Demand Lifts Expectations? - Sahm
The NovaPure Plunger from West Pharmaceuticaltight particle specs for sensitive biologics - AD HOC NEWS
West Pharmaceutical StockSunday background on valuation and growth drivers - AD HOC NEWS
West Pharmaceutical Services (WST) Stock Could Be 6.9% Undervalued on GLP 1 Growth Narrative - Yahoo Finance
Why West Pharmaceutical’s NovaGuard SA Pro quietly matters for everyday injections - AD HOC NEWS
CAH Stock Up Nearly 8% YTD: Will the Uptrend Continue in the Rest of 2026? - TradingView
COR Stock Down Nearly 18% YTD: Should You Buy, Hold or Sell? - TradingView
West Pharmaceutical Services Inc (WST) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cencora Launches Enhanced Nucleus Solution for Specialty Practices - TradingView
West Pharmaceutical stock under pressure after weekly high as technicals suggest range trading ahead - Traders Union
West Pharmaceutical Services Inc - TradingKey
West Pharmaceutical Services Inc (WST) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
West Pharmaceutical Services Inc (WST) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
West Pharmaceutical stock slips to weekly low amid conflicting momentum signals - Traders Union
Why West Pharmaceutical’s NovaPure plungers quietly matter for injectable drugs - AD HOC NEWS
West Pharmaceutical Services Inc (WST) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
West Pharmaceutical Services Inc (WST) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
West Pharmaceutical Services Inc (WST) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
West Pharmaceutical Services Inc (WST) Institutional Confidence - TradingKey
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
West Pharmaceutical Services Strengthens Support for China’s Biologics Ecosystem with Integrated Prefillable Syringe System Launch at CPHI China 2026 - 巴士的報
Aluminum Crimp Vial Seals Market Forecast to 2035: Growth Accelerates on Biologic Drug Surge and RTU Adoption - IndexBox
Reasons to Retain Baxter International Stock in Your Portfolio for Now - TradingView
West pharmaceutical services strengthens support for china’s biologics ecosystem with integrated prefillable syringe system launch at CPHI China 2026 - The Sun Malaysia
West Pharmaceutical Services Strengthens Support for China’s Biologics Ecosystem with Integrated Prefillable Syringe System Launch at CPHI China 2026 #WestPharmaceuticalServices - Media OutReach Newswire
New release highlights: Westar Select Ready Pack vials target small-batch biologics - AD HOC NEWS
New price band, same precision: West’s Stelmi Ready Pack seeks broader biologics use - AD HOC NEWS
How Investors May Respond To West Pharmaceutical Services (WST) Upgraded 2026 Outlook And Biologics Momentum - Yahoo Finance
Is West Pharmaceutical Stock Outperforming the S&P 500? - Yahoo Finance
West Pharmaceutical Stock (US9523901012): Quiet trading day keeps valuation in focus - AD HOC NEWS
West Pharmaceutical Services Inc Azioni (WST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.85%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):